Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
1,235
-
Total 13F shares, excl. options
-
490,576,046
-
Shares change
-
-10,612,627
-
Total reported value, excl. options
-
$38,125,155,854
-
Value change
-
-$832,266,494
-
Put/Call ratio
-
115%
-
Number of buys
-
532
-
Number of sells
-
545
-
Price
-
$77.77
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2025
As of 30 Sep 2025 Edwards Lifesciences Corp - Common Stock (EW) had 1,235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 490,576,046 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, FMR LLC, JENNISON ASSOCIATES LLC, GEODE CAPITAL MANAGEMENT, LLC, and DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main.
This table shows 1,235 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.